相关实验视频
Updated: Sep 14, 2025
10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
12.8K
作为辐射诱导认知衰退的治疗机会的诺拉丁激素激活剂
Isabeau De Bie1, Irina Primac2, Lisa Berden2
1Radiobiology Unit, RadioPharma Research, Nuclear Medical Applications Institute, Belgian Nuclear Research Centre (SCK CEN), Mol, Belgium; 4BRAIN, Department of Head and Skin, Faculty of Medicine and Health sciences, Ghent University, Ghent, Belgium.
概括
通过像reboxetine (REB) 这样的激动剂来增强诺亚上腺素 (NA),可显著地保护海马体免受辐射损伤. 这种治疗可以减少细胞死亡,炎症,并防止儿科患者的记忆力下降,为脑瘤幸存者提供希望.
科学领域:
- 神经科学是一个神经科学.
- 辐射瘤学 辐射瘤学
- 药理学 药理学是指药理学的学科.
背景情况:
- 儿科患者的头辐射可能会导致由于海马体损伤而导致神经认知障碍.
- 辐射诱导的海马体损伤包括神经干细胞/原生细胞 (NSC/NPC) 损失和神经炎症.
- 诺拉丁激素激应剂可以通过减少细胞死亡和炎症来提供神经保护.
研究的目的:
- 评估提高诺亚上腺素 (NA) 是否可以减轻辐射诱导的海马损伤.
- 为了确定NA治疗是否可以防止脑辐射后的记忆衰退.
- 评估诺亚激素激活剂对海马细胞死亡,炎症和神经发生的影响.
主要方法:
- 小鼠接受了10 Gy的头骨辐射,并接受了reboxetine (REB) 或atipamezole (ATI) 的治疗.
- 在不同时间点评估海马细胞死亡,pCREB,BDNF表达,NSC/NPC损失和微质炎症.
- 评估记忆缺陷和海马缩,使用行为测试和MRI 1个月后辐射.
主要成果:
- REB和ATI治疗显著降低了辐射诱导的海马毒性,包括亡和微质炎症.
- 诺拉丁激素激动剂保留了pCREB和BDNF表达,减弱了NSC/NPC损失,并保护了不成熟的神经元.
- REB治疗可以预防海马体体积损失,并成功缓解辐射诱导的记忆功能障碍.
结论:
- 诺拉丁上腺素 (NA) 治疗对辐射诱导的海马损伤有显著的益处.
- 在临床前模型中,reboxetine (REB) 有效地减轻了辐射诱导的记忆功能障碍.
- 在儿童脑瘤幸存者中,NA治疗有潜力管理长期的认知并发症.
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
209
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
209
01:22Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
01:24Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
01:30Adrenergic Agonists: Therapeutic Uses
974
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
974
01:25Adrenergic Agonists: Indirect-Acting Agents
1.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.9K